U.S. Clinical Trial Begins for Cannabis-Based Pain Medication: What Iowa Medical Cannabis Patients Should Know
Updated: Nov 5
Don’t miss important updates about Iowa’s marijuana program. Subscribe to our newsletter and get the latest straight to your email!
A new clinical trial in the United States is investigating a cannabis-based medication for chronic pain, marking an important development in medical marijuana research that could have implications for patients in Iowa and across the country.
Researchers in New York have received authorization to conduct a clinical trial examining the safety and effectiveness of a cannabis-derived medication designed to treat chronic pain. The study focuses on patients experiencing persistent lower back pain, including individuals who have not found adequate relief from conventional pain medications.
The investigational medication, known as VER-01, contains cannabinoids derived from the cannabis plant, including tetrahydrocannabinol (THC).
As more states continue to develop medical cannabis programs, research like this could help healthcare professionals better understand the potential benefits, limitations, and risks of cannabis-based treatments.
For Iowa residents, where chronic pain is already a qualifying condition for a medical marijuana card, the study represents another development worth following.
What Is the New Cannabis-Based Pain Medication Clinical Trial?
The clinical trial is being conducted by Upstate Clinical Research Associates in Williamsville, New York, near Buffalo, as part of a broader research effort involving multiple locations across the United States.
Researchers are evaluating VER-01, an investigational marijuana-based medication developed by German pharmaceutical company Vertanical.
The medication is being studied for its potential to help patients with chronic lower back pain, particularly pain associated with nerve irritation or compression.
Unlike many medical marijuana products currently available through state programs, VER-01 is being evaluated as a standardized pharmaceutical medication through a formal clinical trial.
The study is designed to examine several important questions:
Pain Relief: Can VER-01 meaningfully reduce chronic pain compared with a placebo?
Safety: What side effects or potential risks are associated with the medication?
Long-Term Effectiveness: Can patients experience sustained improvement over time?
Treatment Alternatives: Could cannabis-derived medications eventually provide another option for patients whose pain is not adequately managed with existing treatments?
The U.S. study is placebo-controlled, meaning researchers will compare outcomes among patients receiving the investigational medication and those receiving an inactive treatment.
This approach helps investigators determine whether any observed improvements can be attributed to the medication itself.
What Is VER-01 and How Does It Work?
VER-01 is a cannabis-derived oral medication developed specifically for the treatment of chronic pain.
The formulation contains THC and other marijuana compounds in standardized amounts, allowing researchers to evaluate consistent doses rather than products that may vary in composition.
THC interacts with the body's endocannabinoid system, which plays a role in several physiological processes, including pain signaling, mood, and sleep.
Researchers are investigating whether these interactions can help reduce certain types of chronic pain.
VER-01 has already undergone clinical research in Europe, where studies have reported promising findings in patients with chronic lower back pain.
A large European clinical trial found that participants receiving the cannabis-based medication experienced greater average pain reductions than those receiving a placebo. However, some participants experienced side effects, including dizziness, nausea, and fatigue.
The medication has also received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA), a designation intended to help accelerate the development and review of certain investigational treatments.
Importantly, Breakthrough Therapy Designation does not mean VER-01 has been approved by the FDA. Additional research and regulatory review are required before the medication could become available as an approved prescription treatment in the United States.
Why Marijuana Research Matters for Chronic Pain Patients in Iowa
Chronic pain is one of the qualifying medical conditions recognized under Iowa's Medical Cannabis Program.
For individuals living with persistent pain, finding effective treatment can be challenging. Some patients experience limited relief from traditional medications, while others may struggle with side effects or concerns about long-term medication use.
Medical cannabis has become an area of interest for researchers studying pain management, particularly as healthcare professionals continue exploring additional treatment options.
The VER-01 clinical trial is especially relevant because it examines a standardized cannabis-derived medication under controlled research conditions.
Studies like this may eventually help answer important questions about which patients could benefit from cannabis-based treatments, what doses may be appropriate, and how potential risks compare with other therapies.
Although the research is taking place outside Iowa, its findings could contribute to the broader scientific understanding of medical cannabis and chronic pain.
However, results from VER-01 studies cannot automatically be applied to every medical marijuana product available through Iowa dispensaries. Different products may contain different cannabinoids, concentrations, and formulations.
Chronic Pain Is a Qualifying Condition for an Iowa Medical Cannabis Card
While researchers continue investigating cannabis-based medications, Iowa already operates a regulated medical cannabis program for patients with qualifying medical conditions.
Under Iowa law, chronic pain is an approved qualifying condition for medical marijuana certification.
This means Iowa residents experiencing chronic pain may be eligible to obtain a medical cannabis registration card after receiving certification from an authorized healthcare practitioner.
Other qualifying conditions under Iowa's Medical Cannabis Program include:
Patients must meet the state's eligibility requirements and obtain the necessary healthcare practitioner certification before applying for an Iowa medical cannabis card.
How to Get an Iowa Medical Cannabis Card for Chronic Pain
The first step is scheduling an appointment with a licensed Iowa marijuana doctor - that’s where we come in! At Iowa Marijuana Card, patients can complete their evaluations through secure telemedicine appointments from the comfort of home. Telemedicine has made certification more accessible for patients throughout the state, especially those managing conditions that make travel difficult.
During your appointment, one of our experienced marijuana doctors will review your medical history, discuss your symptoms, and determine whether medical marijuana may be appropriate for your condition. If approved, your marijuana doctor will complete the required certification and guide you through the next steps.
After receiving certification, our team helps patients complete the state registration process. After submitting your application, the state will review your information within 3 to 5 business days, and, if approved, your Iowa medical marijuana card will be sent to you by email. Patients can digitally download their card on their phone or print it and use it to legally visit licensed Iowa dispensaries and purchase medical marijuana products. Patients must also bring a government-issued ID in order to visit dispensaries.
What Medical Marijuana Products Are Available in Iowa?
Iowa's Medical Cannabis Program allows registered patients to purchase approved cannabis products from licensed dispensaries.
Permitted product forms include:
However, Iowa prohibits certain forms of marijuana, including raw cannabis flower intended for smoking.
The state also generally limits registered patients to purchasing products containing a combined total of 4.5 grams of THC over a 90-day period, although certain exceptions and practitioner-authorized waivers may apply.
Patients should speak with their healthcare practitioner about the potential risks and benefits of medical cannabis, particularly when managing chronic pain or taking other medications.
What Could This Clinical Trial Mean for the Future of Medical Marijuana?
The VER-01 clinical trial represents an effort to evaluate cannabis-based pain treatments using the same scientific standards applied to other prescription medications.
If researchers establish that the medication is both safe and effective for specific types of chronic pain, the findings could support future regulatory decisions and additional research.
For Iowa medical cannabis patients, continued research may help improve understanding of cannabis-derived medications and their potential role in pain management.
However, it is important to distinguish investigational pharmaceutical medications like VER-01 from products currently available through state medical cannabis programs.
The new clinical trial does not change Iowa's existing medical cannabis laws, qualifying conditions, or patient registration requirements.
For now, Iowa residents interested in medical cannabis must continue following the state's established certification and registration process.
Get Your Marijuana Card!
Before purchasing or using medical marijuana in Iowa, patients must first receive approval through the state's medical marijuana program. Only registered patients with a valid Iowa medical marijuana card may legally purchase medical marijuana products from licensed dispensaries or receive the legal protections provided under Iowa law.
Getting your card is simple. Schedule a telemedicine appointment with one of our licensed marijuana doctors, complete your evaluation, and if approved, we'll provide the certification needed for your state application. Our patient support team will also help you submit your application to the state during your appointment, making the process as simple and stress-free as possible.
Don’t wait to get the relief you deserve! Schedule an evaluation online today with one of our knowledgeable, compassionate marijuana doctors via telemedicine!
Doctors Who Care.
Relief You Can Trust.
At Iowa Marijuana Card, we’re here to make the process easy and stress-free. Our team is dedicated to helping you unlock the full benefits of Iowa's medical marijuana program while improving your overall quality of life.
Don’t wait to start feeling better. Call us at 866-443-1122 or schedule a medical marijuana evaluation today and take advantage of the many benefits a medical card has to offer!
For more blogs like this, plus patient resources and state updates, subscribe to our newsletter!
Comments